SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : RXSD Rexall Sundown

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: cadson who wrote (26)7/15/1998 11:20:00 AM
From: The ChrisMeister  Read Replies (1) of 327
 
"...I think we will see a five point run as the shorts are forced to cover."

I think five points is a conservative estimate. That ratio of the number of shares short divided by the average daily volume is huge. When you add in those who buy off the new highs list, plus the momentum players, I think you have the makings of a run to the mid-to-high 50's. Yes, a 50% pop is not beyond believability. With the Pfizers and Schering-Ploughs selling at huge P/E's (70 and 50, respectively, I think) and only 15-20% growth rates, RXSD is gonna look cheap until it's way higher.

It's either that or the shorts have a huge pile of ammo and beat us back here at the 38th parallel. Hard to understand why there are so many short shares out there...

ChrisMeister
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext